Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.

Scandinavian journal of rheumatology - 1 Jan 2000

Sallai K K, Nagy E, Bodó I, Mohl A, Gergely P

Abstract excerpt

OBJECTIVES: Thromboembolic episodes are frequent manifestations of systemic lupus erythematosus (SLE). Although the presence of anti-phospholipid antibodies (aPL) is known to contribute to thromboembolism (TE), the relative contribution of other TE risk factors is unknown. The aim of this study was to determine the prevalence of TE in a Caucasian SLE population, to identify the risk factors of highest importance,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antiphospholipid
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Factor VIII

Share to Lupus Erythematosus, Systemic

Share to Thrombophilia

Share to Thrombosis

Share to von Willebrand Factor

Source

Identifiers

PMID: 17657674
DOI: 10.1080/03009740601089283

Genes

GPI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.PMID 17657674Read ↗

Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.Semantic proximity Read ↗

Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.Semantic proximity Read ↗

Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.Semantic proximity Read ↗

Genetic risk factors for thrombosis in systemic lupus erythematosus.Semantic proximity Read ↗

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLESemantic proximity Read ↗

HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.Semantic proximity Read ↗

Factor V Leiden and prothrombin G20210A mutations and the risk of atherothrombotic events in systemic lupus erythematosus.Semantic proximity Read ↗

The Leiden mutation of coagulation factor V in Hungarian SLE patients.Semantic proximity Read ↗

Thrombosis in systemic lupus erythematosus: effect of inherited thrombophilic mutations.Semantic proximity Read ↗

Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations.Semantic proximity Read ↗

Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus.Semantic proximity Read ↗

Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.